Risk Factors for Hepatosplenic Abscesses in Patients With Acute Leukemia Receiving Empiric Azole Treatment
- 31 December 1994
- journal article
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 308 (6) , 309-312
- https://doi.org/10.1097/00000441-199412000-00001
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Notable clinical changes of hepatosplenic abscesses in febrile neutropenic patients receiving empiric antifungal treatment with azolesEuropean Journal of Haematology, 1994
- Hepatic and splenic abscesses — a common complication of intensive chemotherapy of acute myeloid leukemia (AML)Annals of Hematology, 1991
- Hepatosplenic candidiasis, a late manifestation of Candida septicaemia in neutropenic patients with haematologic malignanciesAnnals of Hematology, 1990
- Candida colonization and systemic infection in neutropenic patients. A retrospective studyCancer, 1989
- Hepatic Candidiasis in Cancer Patients: The Evolving Picture of the SyndromeAnnals of Internal Medicine, 1988
- Hepatic Candidiasis: An increasing problem in immunocompromised patientsThe American Journal of Medicine, 1987
- Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemiaCancer, 1984
- Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopeniaThe American Journal of Medicine, 1982